Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children

Molecular Psychiatry

Volumn 4, Issue 2, 1999, Pages 192-196

  Daly, G ^b   Hawi, Z ^b   Fitzgerald, M ^b   Gill, M ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b NONE

Author keywords

ADHD; Association; Genetics; Psychiatry

Indexed keywords

DOPAMINE 5 RECEPTOR; DOPAMINE TRANSPORTER;

ADOLESCENT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; DOPAMINERGIC SYSTEM; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMPULSIVENESS; INHERITANCE; IRELAND; MAJOR CLINICAL STUDY; MALE; MOTOR ACTIVITY; NORADRENERGIC SYSTEM; PRIORITY JOURNAL;

EID: 0032910655     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000510     Document Type: Article

References (34)

1. Taylor E, Chadwick O, Heptinstall E, Danckaerts M. Hyperactivity and conduct problems as risk factors for adolescent development, J Am Acad Child Adolesc Psychiatry 1996; 35: 1213-1226.
2. Pliszka SR, McCracken JT, Maas JW. Catocholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 1996; 35: 264-272.
3. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 1997; 2: 311-313.
4. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (4th edn). Washington, DC, 1994.
5. Taylor E. The Epidemiology of Childhood Hyperactivity. Maudsley Monographs No. 33, Oxford University Press, 1991.
6. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C et al. Further evidence for family-genetic risk factors in ADHD: patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 1992; 49: 728-738.
7. Thapar A, Hervas A, McGuffin P. Childhood hyperactivity scores are highly heritable and show sibling competition effects: twin study evidence. Behav Genet 1995; 25: 537-544.
8. Levy F, Hay DA, McStephen M, Wood C, Waldman L. Attention deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 1997; 36: 737-744.
9. Eaves LJ, Silberg JL, Meyer JM, Maes HH, Simonoff E, Pickles A et al. Genetics and developmental psychopathology: 2. The main effects of genes and environment on behavioral problems in the Virginia twin study of adolescent behavioral development. J Child Psychol Psychiatry 1997; 38: 965-980.
10. Smalley SL. Genetic influences in childhood-onset psychiatric disorders: autism and attention-deficit/hyperactivity disorder. Am J Hum Genet 1997; 60: 1276-1282.
11. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
12. Cook EM, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56: 993-998.
13. Vandenberg DJ, Persico AM, Hawkins AL, Griffin CA et al. Human dopamine transmitter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992; 14: 1104-1106.
14. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL et al. Association and linkage of the dopamine transporter gene and attention deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet (in press).
15. Donovan DM, Vandenbergh DJ, Perry MP, Bird GS, Ingersoll R, Nanthakumar E et al. Human and mouse dopamine transporter genes: conservation of 5′-flanking sequence elements and gene structures. Brain Res Mol Brain Res 1995; 30: 327-335.
16. Giros B, Jaher M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996; 379: 606-612.
17. Vuchetich JP, Dunnette J, Lunetta KL, Weinshilboum RM, Price RA. Inheritance of human plasma dopamine-beta-hydroxylase. Genet Epidemiol 1991; 8: 237-251.
18. Sunohara RK, Guan HC, O'Dowd BF, Sceman P, Laurier LG, Ng G et al. Cloning of the gene for a human dopamine D5-receptor with higher affinity for dopamine than D1. Nature 1991; 350: 614-619.
19. Sherrington R, Mankoo B, Attwood J, Kalsi G, Curtis D, Buetow K et al. Cloning of the human dopamine D5 receptor gene and identification of a highly polymorphic microsatellite for the DRD5 locus that shows tight linkage to the chromosome 4p reference marker Rafp1. Genomics 1993; 18: 423-425.
20. Schaid D, Sommer SS. Comparison of statistics for candidate-gene association studies. Am J Hum Genet 1994; 55: 402-409.
21. Castellanos FX, Giedd JN, Eckburg P, Marsh WL, Vaituzis AC, Kaysen D et al. Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. Am J Psychiatry 1994; 151: 1791-1796.
22. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS et al. Is methylphenidate like cocaine? Studies on their pharmcokinetics and distribution in the human brain. Arch Gen Psychiatry 1995; 52: 456-463.
23. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1: 121-124.
24. Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wigal T et al. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 1998; 3: 38-41.
25. Smalley SL, Bailey JN, Palmer C, Cantwell D, McGough J, Del'Homme MA et al. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry 1998; 3: 427-430.
26. Rowe DC, Stever C, Giedinghagen LN, Gard JMC, Cleveland HH, Terris ST et al. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry 1998; 3: 419-426
27. Castellanos FX, Lau E, Tayebi N, Lee P, Long RE, Giedd JN et al. Lack of an association between a dopamine-4 receptor polymorphism and attention deficit/hyperactivity disorder: genetic and brain morphometric analyses. Mol Psychiatry 1998; 3: 431-434.
28. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150: 885-890.
29. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953; 9: 531-541.
30. Achenbach TM. Manual for the Child Behaviour Checklist and 1991 Profile. Department of Psychiatry, University of Vermont, Burlington, 1991.
31. Conners CK. Rating scales in attention deficit hyperactivity disorder: use in assessment and treatment monitoring. J Clin Psychiatry 1998; 59(S7): 24-30.
32. Ullman RK, Sleator EK, Sprague RL. A new rating scale for diagnosis and monitoring of attention deficit children. Psychopharmacol Bull 1984; 20: 160-164.
33. Terwilliger JD, Ott J. A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum Heredity 1992; 42: 337-346.
34. Curtis D, Sham PC. A note on the application of the Transmission Disequilibrium Test when a parent is missing. Am J Hum Genet 1995; 56: 811.